Targeting FGFR4 abrogates HNF1A-driven metastasis in pancreatic ductal adenocarcinoma is a research paper published in Molecular Cancer (2025). On theSindex it has a DataRank of 0. It has been cited 3 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
National Cancer Institute
Grant: CA267467
National Cancer Institute
Grant: R01CA279713
National Cancer Institute
Grant: R37CA275691
Pancreatic Cancer Action Network
Grant: 167025ABEL
NCI NIH HHS
Grant: L70 CA275691
NCI NIH HHS
Grant: R37 CA275961
National Institutes of Health
Grant: 5R37CA275961-03
Targeting HNF1A-mediated therapeutic resistance in pancreatic ductal adenocarcinoma
National Institutes of Health
Grant: 5P30CA016056-40
Roswell Park Cancer Institute Cancer Center Support Grant
National Institutes of Health
Grant: 1R01CA279713-01
RBFOX2 deregulation promotes pancreatic cancer progression through alternative splicing
National Institutes of Health
Grant: 5R01CA211878-03
Common Genetically Altered Pathways as Targets for Therapy in Pancreatic Cancer
Roswell Park Alliance Foundation
Hirshberg Foundation for Pancreatic Cancer Research
SAS Foundation for Cancer Research
FWCI
1.37
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Additional file 1 of Targeting FGFR4 abrogates HNF1A-driven metastasis in pancreatic ductal adenocarcinoma
Additional file 1 of Targeting FGFR4 abrogates HNF1A-driven metastasis in pancreatic ductal adenocarcinoma